Home > Education Hub > Eurobiomed: US Webinar Cycle: Market Access & Regulatory Aspects

Eurobiomed: US Webinar Cycle: Market Access & Regulatory Aspects

November 9, 2021

Events

Category:

Market Access

Published on:

November 2, 2021

Schedule

Introduction to this webinar series

Regulatory aspects, pricing and reimbursement in the USA
Overview of US Medtech regulation – Vincent Casteras- Associate Director – Nexialist
Pricing and drug reimbursement: understanding US payers – Pepi HURTADO, PhD, Director of Global Market Access – Alira Health

Meet the Team Attending:

Pepi Hurtado, PhD

Director, Global Market Access

Learn more about the webinar here

Related news

Webinars March 28, 2025

How Sustainability and Health Equity Are Reshaping Market Access Policy in Europe

This webinar will explore sustainability and health equity impact on reimbursement and procurement decisions in Europe and provide practical insights on how companies can adapt to the new landscape.

EU Market Access Sustainability

Articles March 6, 2025

ATMPs: Access, Pricing, and Ethical Issues in Perspective

Start reading this sneak peek of our recent analysis of access, pricing and ethical issues for advanced therapies medicinal products.

Advanced Therapies Market Access Orphan Drug Pricing

Articles February 17, 2025

Sustainable Pricing: An Opportunity to Improve Patient Access

Discover key pricing strategies to improve pharmaceutical health equity and price sustainability.

Market Access Pricing Sustainability

Articles January 24, 2025

How to Navigate the JCA Era: Market Access Strategy Optimization in the EU

With the JCA now in effect, we spoke with Andrea Mantovani, Alira Health Partner, Market Access and Pricing, about its impact on pharmaceutical companies hoping to bring new therapies to market.

EU Market Access

News January 8, 2025

Alira Health Launches the Global Payer Forum 2025 in Partnership with UPF Barcelona School of Management, NEWDIGS at Tufts Medical Center, and the University College of London

Alira Health is excited to announce the second year of the Global Payer Forum, a landmark educational initiative in partnership with distinguished academic institutions, UPF Barcelona(...)

Health Policy Market Access Pharma

Articles December 18, 2024

Market Access and Pricing Landscape for Diagnostic Radiopharmaceuticals

Discover the current market access and pricing landscape for diagnostic radiopharmaceuticals in key European markets, including the specific challenges, and discusses best practices(...)

Market Access Pricing Radiopharmaceuticals

Articles November 12, 2024

Funding and Procurement Trends in Radiopharmaceuticals

Discover how funding and procurement processes for commercial radiopharmaceuticals vary across Europe, including factors driving purchasing decisions.

Market Access Nuclear Medicine Radioligand Therapies (RLTs)